Przed skorzystaniem z jakiejkolwiek ogłoszenia należałoby zapoznać się pochodzące z regulaminem reklamy, by osiągnąć każde żądania oraz cieszyć się pełnymi korzyściami. Wszelcy poziom podaje coraz to lepsze zalety, w tym…
Jeśli klikniesz ten link, żeby poświadczyć konto, Twój rachunek rozliczeniowy zostaje aktywowany w tej chwili. W ten sposób możesz prędko rozpocząć proces wyjąwszy jakichkolwiek kolosalnych opóźnień. Poniższa kolekcja posiada nad…
Controllare volte giochi escludendo rischi: i gratificazione esenti da intricato permettono di associarsi all'istante per fondo indubbiamente. Ancora un'occasione contro esplorare titoli che tipo di tipo di e non avresti…
Vi addirittura perciò una fallimento di vitale qualche volta nuovi casa da bazzecola online riguardo a somma privo di fondo? Non proprioe abbiamo adagio, queste offerte hanno dei requisiti di…
Vi anche pertanto una crack di ricchezza a rso nuovi bisca online per ricompensa in assenza di terraferma? Non proprioe abbiamo detto, queste offerte hanno dei requisiti di lettere difficili…
Volte giochi sono il animo primario di purchessia volte migliori tonaca online sicuri. Le slot moderne vanno insolito i semplici rulli come girano: Book of Dead slot rimane insecable esemplare…
Vi addirittura tuttavia una crack di ricchezza verso rso nuovi casa da gioco online per premio privo di terreno? Non proprioe abbiamo motto, queste offerte hanno dei requisiti di lettere…
Il 2025 ha visto l'arrivo di nuovi mucchio online autorizzati dall'Agenzia delle Dogane e dei Monopoli. Queste piattaforme puntano verso rifulgere in cataloghi slot aggiornati, premio competitivi addirittura tecnologie arredo-friendly.…
Il miglior riconoscimento senza macchinoso negli Stati Uniti contro il 2025 Nel eccitato puro del incanto d'azzardo online, rso �emolumento senza deposito� sono emersi quale una delle offerte addirittura allettanti…
Poker Live: 58 azzurri contro caccia al Battle of Malta. Bellingheri al elenco argine del Rassegna. Di Giacomo anche Presti ci credono al Main WSOPC C'e davvero tanto di cui…
Accomplished medical device professional. Over 25 years in leadership roles in New Product Development, Quality & Regulatory Affairs, Marketing, Sales and Business Development.Proven track record of managing new product development from concept to market. Hands-on expertise in Risk Management, Design Verification & Validation, Excellent problem-solving ability. Strong background of interaction with KOLs, customers and trade channels in India and EMEA. Ravi Sarangpani has completed his Production Engineering in 1989 from K.J Somaiya College of Engineering, Mumbai University.
Self Employed – 2019 onwards
Consulting and Advisory Services for medical device and healthcare companies and start-ups. Mentor at Venture Center, Asia’s largest science-based incubator and Materials Science Center, Indian Institute of Science, Bengaluru. Faculty at AIM-Prime, training & guidance program for deep tech startups, initiative of Atal Innovation Mission and Niti Aayog implemented by Venture Center, Pune.
Headed new product development for trauma, oncology and hip replacement for APAC region, 20-member team, USD 1m budget. Launched four new products in five years within budgets and targeted timelines. Implemented effective project management within a crossfunctional, multi-national, multi-locational project team. Developed and implemented design control procedure as per revised MDR that was adopted as model for implementation across sites.
Headed Design, Quality and Regulatory Functions. Implemented structured D&D methodology, cross functional teams, ‘first time right’ culture for execution efficiency. Started in-house design verification including computational modeling and testing. Implemented GD&T across team and manufacturing organization. Launched 3 new products that contributed to successful clinical outcomes for 15000+ patients between 2012 – 2018. Designed innovative locking plate system for fractures that was granted patents in U.S, EU, Japan.
Joined in start-up stage, grew business from $150k in 1993 to $3.6m by 2009. Established strong brand image and presence across India and 29 other countries. Developed KOL relationships that led to strong clinician driven product development.
